He A - Search Results

1

Curcumin inhibits the proliferation and invasion of MG-63 cells through inactivation of the p-JAK2/p-STAT3 pathway.

Sun Y, Liu L, Wang Y, He A, Hu H, Zhang J, Han M, Huang Y. Sun Y, et al. Among authors: he a. Onco Targets Ther. 2019 Mar 15;12:2011-2021. doi: 10.2147/OTT.S172909. eCollection 2019. Onco Targets Ther. 2019. PMID: 30936718 Free PMC article.

2

Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.

He A, Qi W, Huang Y, Sun Y, Shen Z, Zhao H, Yang Y, Yao Y. He A, et al. Int J Clin Oncol. 2013 Jun;18(3):498-505. doi: 10.1007/s10147-012-0409-5. Epub 2012 Apr 26. Int J Clin Oncol. 2013. PMID: 22534798

3

Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta-analysis of clinical trials.

Qi WX, Shen Z, Lin F, Sun YJ, Min DL, Tang LN, He AN, Yao Y. Qi WX, et al. Br J Clin Pharmacol. 2013 Apr;75(4):919-30. doi: 10.1111/j.1365-2125.2012.04417.x. Br J Clin Pharmacol. 2013. PMID: 22882307 Free PMC article. Review.

4

Overall survival benefits for irinotecan-containing regimens as first-line treatment for advanced gastric cancer: an updated meta-analysis of ten randomized controlled trials.

Qi WX, Shen Z, Lin F, Sun YJ, Min DL, Tang LN, He AN, Yao Y. Qi WX, et al. Int J Cancer. 2013 Jan 15;132(2):E66-73. doi: 10.1002/ijc.27775. Epub 2012 Sep 1. Int J Cancer. 2013. PMID: 22890856 Review.

5

Cyclophosphamide-hydroxycamptothecin as second-line chemotherapy for advanced Ewing's sarcoma: experience of a single institution.

Han K, Sun Y, Zhang J, He A, Zheng S, Shen Z, Yao Y. Han K, et al. Among authors: he a. Asia Pac J Clin Oncol. 2014 Jun;10(2):e114-7. doi: 10.1111/ajco.12018. Epub 2012 Nov 26. Asia Pac J Clin Oncol. 2014. PMID: 23176372 Clinical Trial.

6

Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis.

Qi WX, Lin F, Sun YJ, Tang LN, He AN, Yao Y, Shen Z. Qi WX, et al. Cancer Chemother Pharmacol. 2013 Feb;71(2):431-9. doi: 10.1007/s00280-012-2025-5. Epub 2012 Nov 21. Cancer Chemother Pharmacol. 2013. PMID: 23178953

7

CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study.

He A, Qi W, Huang Y, Feng T, Chen J, Sun Y, Shen Z, Yao Y. He A, et al. Exp Ther Med. 2012 Sep;4(3):435-441. doi: 10.3892/etm.2012.603. Epub 2012 Jun 8. Exp Ther Med. 2012. PMID: 23181114 Free PMC article.

8

Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Qi WX, Shen Z, Lin F, Sun YJ, Min DL, Tang LN, He AN, Yao Y. Qi WX, et al. Curr Med Res Opin. 2013 Feb;29(2):117-25. doi: 10.1185/03007995.2012.756393. Epub 2012 Dec 26. Curr Med Res Opin. 2013. PMID: 23216340 Review.

9

Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysis.

Qi WX, Min DL, Shen Z, Sun YJ, Lin F, Tang LN, He AN, Yao Y. Qi WX, et al. Int J Cancer. 2013 Jun 15;132(12):2967-74. doi: 10.1002/ijc.27979. Epub 2012 Dec 27. Int J Cancer. 2013. PMID: 23225494 Review.

10

Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung cancer: a systematic review and meta-analysis.

Qi WX, Shen Z, Lin F, Sun YJ, Min DL, Tang LN, He AN, Yao Y. Qi WX, et al. Asian Pac J Cancer Prev. 2012;13(10):5177-82. doi: 10.7314/apjcp.2012.13.10.5177. Asian Pac J Cancer Prev. 2012. PMID: 23244131 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,730 results

Search Page

Filters